Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ENDOSSEOUS DENTAL IMPLANT PLACEMENT IN FOUR SUBGROUPS RECOMMENDED BY FDA DENTAL PRODUCTS PANEL; IMPLANT ABUTMENTS SHOULD BE CLASSIFIED SEPARATELY

This article was originally published in The Gray Sheet

Executive Summary

Endosseous dental implants should be placed in four separate subgroups for consideration of reclassification, FDA's Dental Products Panel concluded at a Nov. 4 meeting in Bethesda, Maryland. The four subgroups -- root form implants, blade implants, implants with special retention features and temporary implants -- represent device types for which different degrees of regulatory control may be required to assure safety and effectiveness, the panel stated.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009115

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel